Followers | 37 |
Posts | 4190 |
Boards Moderated | 0 |
Alias Born | 10/18/2016 |
Friday, September 01, 2017 12:14:43 PM
The legal cannabis market is exploding in North America and especially in Canada, where medical marijuana has been legal on a national level since 2001 and where sweeping legislation has been introduced in an effort to nationally legalize recreational use, as well. Among cannabis players preparing to capitalize should recreational legalization happen is Algae Dynamics Corp. (OTCQB: ADYNF). An excerpt from an article further discussing this reads: “Algae Dynamics is focused on cannabis oil extraction and medicine delivery systems, endeavoring to offer medical cannabis users a means of enjoying the benefits of medical marijuana without smoking. The company is preparing to exploit a niche market with its development of unique health products and pharmaceuticals utilizing hemp, cannabis and algae oils. If recreational cannabis is successfully legalized on a national scale, Canada’s market for oil extraction is projected to grow to C$1.5 billion by 2020. In Colorado, 45 percent of cannabis consumers who use dried marijuana have said they would eventually switch over to marijuana extracts and oil, and a similar conversion rate is anticipated for Canada’s market. In view of this, Algae Dynamics is extremely well-positioned for success.”
To view the full article, visit http://nnw.fm/LDeW0
About Algae Dynamics Corp.
ADC is engaged in the development of unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils. We have engaged two Canadian universities to provide research into the use of extracts from cannabis oil, which we plan to use to develop products that combine the significant health benefits of Omega-3s derived from algae oil and extracts from cannabis oil. Our research is focused on the use of cannabis oil in the context of cancer, and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health. For more information, visit http://www.algaedynamics.com.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM